Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4405 results

Sort By:

MyStroke for Stroke Survivors and Caregivers

Study ID: NCT06442631
Start Date: 2025-07-01
End Date: 2029-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

586

Intervention / Treatment

MyStroke

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

Study ID: NCT06654882
Start Date: 2025-02
End Date: 2034-05
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

TNFi (Tumor Necrosis Factor inhibitor) medication

Abatacept

Tocilizumab

Tofacitinib

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Study ID: NCT05253131
Start Date: 2024-12-15
End Date: 2030-12-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

41

Intervention / Treatment

Selumetinib

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Interaction Between Early Trauma and Odor-induced Dopamine Release

Study ID: NCT06284382
Start Date: 2024-12-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

High score at Childhood Trauma Questionnaire.

Low score at Childhood Trauma Questionnaire.

Sponsor

Vinatier Hospital

Source: clinicaltrials.gov

Share:
Add to list

Tofacitinib in Patients With Amyotrophic Lateral Sclerosis

Study ID: NCT06689982
Start Date: 2024-12-01
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

12

Intervention / Treatment

Tofacitinib tablets

Sponsor

Beijing Tia Ntanhospital

Source: clinicaltrials.gov

Share:
Add to list

Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer

Study ID: NCT06697782
Start Date: 2024-12-01
End Date: 2025-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Ondansetron 8mg

Aprepitant 125 mg

Sponsor

The First Affiliated Hospital of Zhengzhou University

Source: clinicaltrials.gov

Share:
Add to list

PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study

Study ID: NCT05377320
Start Date: 2025-06
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Clinical Decision Aid

Standard Care

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

Study ID: NCT06701682
Start Date: 2024-12-27
End Date: 2028-02-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Cohort A: vilobelimab

Cohort A: placebo

Sponsor

PPD DEVELOPMENT, LP

Source: clinicaltrials.gov

Share:
Add to list

FatMax Training on Metabolic and Epigenetic Parameters

Study ID: NCT06553482
Start Date: 2025-01-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

156

Intervention / Treatment

FatMAx training intervention

FatMax and physical endurance exercise intervention

Control

Sponsor

Autonomous University of Baja California

Source: clinicaltrials.gov

Share:
Add to list

Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia

Study ID: NCT03974620
Start Date: 2024-12-01
End Date: 2024-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Individual Placement and Support

Cognitive Remediation Therapy

Sponsor

Pakistan Institute of Living and Learning

Source: clinicaltrials.gov

Share:
Add to list